Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001641172-25-003454
Filing Date
2025-04-09
Accepted
2025-04-09 17:27:44
Documents
3
Period of Report
2025-04-09

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 33462
2 ex99-1.htm EX-99.1 48536
3 ex99-1_001.jpg GRAPHIC 9125
  Complete submission text file 0001641172-25-003454.txt   96037
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
COSCIENS Biopharma Inc. (Filer) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 25826006
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)